Abstract
Using cDNA microarray we have identified several differently expressed and regulated genes in leiomyoma and matched myometrium of untreated cohorts and in women with symptomatic leiomyoma who received gonadotropin releasing hormone analogue (GnRHa) therapy. To validate the microarray results, we used Real-time polymerase chain reaction (PCR) to evaluate the expression of two genes, fibromodulin and Abl-interactor 2 (Abi-2), which were identified as differentially expressed in leiomyomata and myometrium and regulated by GnRHa therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
